Page last updated: 2024-08-24

lamivudine and Icterus

lamivudine has been researched along with Icterus in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's4 (57.14)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chiba, T; Nakanishi, Y; Seno, H; Yamashita, Y1
Akuta, N; Arase, Y; Hosaka, T; Ikeda, K; Kawamura, Y; Kobayashi, M; Kumada, H; Mori, N; Saito, S; Sezaki, H; Suzuki, F; Suzuki, Y1
Hasegawa, K; Hashimoto, E; Hayashi, N; Iizuka, A; Ishikawa, K; Joh, R; Kanai, N; Naritomi, T; Ogawa, M; Shizuma, T; Torii, N1
Chan, FK; Chan, HL; Hui, Y; Leung, NW; Sung, JJ; Tsang, SW1
Chan, HL; Leung, WK; Song, W1
Ahmed, A; Cohn, G; Ehrenpreis, ED; Lissoos, TW; Schiano, TD; Siano, C; Zaitman, D1
de Man, RA; Honkoop, P; Niesters, HG; Schalm, SW; Zondervan, PE1

Trials

1 trial(s) available for lamivudine and Icterus

ArticleYear
The role of lamivudine and predictors of mortality in severe flare-up of chronic hepatitis B with jaundice.
    Journal of viral hepatitis, 2002, Volume: 9, Issue:6

    Topics: Adult; Bilirubin; DNA, Viral; Female; Hepatitis Antibodies; Hepatitis B virus; Hepatitis B, Chronic; Humans; Jaundice; Lamivudine; Male; Middle Aged; Platelet Count; Predictive Value of Tests; Reverse Transcriptase Inhibitors; Survival Analysis

2002

Other Studies

6 other study(ies) available for lamivudine and Icterus

ArticleYear
Education and imaging. Hepatobiliary and pancreatic: multiple sexually transmitted infections.
    Journal of gastroenterology and hepatology, 2010, Volume: 25, Issue:4

    Topics: Acute Disease; Anti-Infective Agents; Antiprotozoal Agents; Antiviral Agents; Colonoscopy; Entamoebiasis; Gastrointestinal Hemorrhage; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Homosexuality, Male; Humans; Immunoglobulin M; Jaundice; Lamivudine; Male; Metronidazole; Middle Aged; Penicillins; Rectum; Syphilis Serodiagnosis; Syphilis, Cutaneous; Unsafe Sex

2010
Determinants of the clinical outcome of patients with severe acute exacerbation of chronic hepatitis B virus infection.
    Journal of gastroenterology, 2012, Volume: 47, Issue:9

    Topics: Adult; Alanine Transaminase; Bilirubin; Disease Progression; Disseminated Intravascular Coagulation; DNA, Viral; Female; Glucocorticoids; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Jaundice; Lamivudine; Male; Middle Aged; Prognosis; Prospective Studies; Prothrombin; Treatment Outcome; Viral Load; Young Adult

2012
Repeated jaundice due to YMDD mutant in a patient with prolonged lamivudine therapy for chronic hepatitis B under prednisolone treatment for Still's disease.
    Internal medicine (Tokyo, Japan), 2002, Volume: 41, Issue:9

    Topics: Amino Acid Sequence; DNA, Viral; Drug Resistance, Viral; Female; Glucocorticoids; Hepatitis B, Chronic; Hepatitis Viruses; Humans; Jaundice; Lamivudine; Middle Aged; Molecular Sequence Data; Mutation; Polymerase Chain Reaction; Prednisolone; Recurrence; Reverse Transcriptase Inhibitors; Sequence Analysis, DNA; Still's Disease, Adult-Onset; Virus Replication

2002
Icteric flare of chronic hepatitis B in a 95-year old patient.
    World journal of gastroenterology, 2003, Volume: 9, Issue:12

    Topics: Aged; Aged, 80 and over; Antiviral Agents; Fatal Outcome; Hepatitis B, Chronic; Humans; Jaundice; Lamivudine; Male

2003
Lamivudine-stavudine-induced liver failure in hepatitis B cirrhosis.
    The American journal of gastroenterology, 1997, Volume: 92, Issue:9

    Topics: Aged; Anti-HIV Agents; Ascites; Drug Combinations; Hepatitis B; Hepatitis, Chronic; HIV Infections; Humans; Jaundice; Lamivudine; Liver Cirrhosis; Liver Failure; Male; Reverse Transcriptase Inhibitors; Stavudine

1997
Acute exacerbation of chronic hepatitis B virus infection after withdrawal of lamivudine therapy.
    Hepatology (Baltimore, Md.), 2000, Volume: 32, Issue:3

    Topics: Adult; Drug Administration Schedule; Hepatitis B, Chronic; Humans; Jaundice; Lamivudine; Liver Failure; Male; Retreatment; Reverse Transcriptase Inhibitors; Time Factors

2000